Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Monoclonal antibodies (mAbs) are nature's biological ... reaching a “peak” of eight products during the year 1991 (see Fig. 1). Chimeric mAbs were less evident: Between two and four products ...

In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

About 6% of pregnancy-related cancers are Hodgkin lymphoma, and 5% are non-Hodgkin lymphoma. Leukemias in pregnancy are rarer, accounting for 1 in 10,000 pregnancies. The most common pregnancy-related ...

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient ...

The company is utilizing advanced technologies such as Chimeric Antigen Receptor T-cell (CAR-T ... ADCs combine the specificity of monoclonal antibodies with the potency of chemotherapy, delivering a ...

a fully-human anti-VEGF monoclonal antibody; HALPRYZA, a recombinant chimeric murine/human anti-CD20 monoclonal antibody; SULINNO, a fully-human antiTNF-a monoclonal antibody; Pemazyre ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The ongoing development of monoclonal antibodies, CAR-T cell therapies ... The growing focus on CAR-T (Chimeric Antigen Receptor T-cell) therapies is another key trend. CAR-T therapies, which involve ...